| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| DEFA1 |
P59665
|
defensin alpha 1
|
|
|
0.636 |
0.731 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| SRY |
Q05066
|
sex determining region Y
|
Transcription factor
|
|
0.456 |
0.808 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| FCGR2C |
P31995
|
Fc fragment of IgG receptor IIc (gene/pseudogene)
|
Cell adhesion
|
|
0.610 |
0.654 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| SPZ1 |
Q9BXG8
|
spermatogenic leucine zipper 1
|
|
|
0.507 |
0.769 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| PTPRVP |
|
protein tyrosine phosphatase receptor type V, pseudogene
|
|
|
0.705 |
0.577 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| SUMO4 |
Q6EEV6
|
small ubiquitin like modifier 4
|
|
|
0.653 |
0.577 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |